Healthcare provider profile · identity verified

Laura Chiles Larch, M.D.

Internal Medicine · JEFFERSONVILLE, IN · NPI 1689625824

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	449	133
Levothyroxine Sodium	Levothyroxine Sodium	365	99
Losartan Potassium	Losartan Potassium	270	86
Rosuvastatin Calcium	Rosuvastatin Calcium	251	79
Escitalopram Oxalate	Escitalopram Oxalate	234	66
Metoprolol Succinate	Metoprolol Succinate	231	70
Amlodipine Besylate	Amlodipine Besylate	222	66
Pantoprazole Sodium	Pantoprazole Sodium	211	70
Lisinopril	Lisinopril	200	56
Omeprazole	Omeprazole	182	46
Alprazolam	Alprazolam	178	36
Hydrochlorothiazide	Hydrochlorothiazide	177	55
Meloxicam	Meloxicam	144	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	139	38
Temazepam	Temazepam	135	32
Potassium Chloride	Potassium Chloride	110	37
Gabapentin	Gabapentin	108	29
Montelukast Sodium	Montelukast Sodium	103	27
Clopidogrel	Clopidogrel Bisulfate	101	33
Allopurinol	Allopurinol	97	30
Ozempic	Semaglutide	91	16
Metformin Hcl Er	Metformin Hcl	90	26
Glimepiride	Glimepiride	87	23
Atenolol	Atenolol	85	22
Zolpidem Tartrate	Zolpidem Tartrate	85	23
Metformin Hcl	Metformin Hcl	76	24
Tramadol Hcl	Tramadol Hcl	73	15
Simvastatin	Simvastatin	72	21
Ezetimibe	Ezetimibe	71	20
Albuterol Sulfate Hfa	Albuterol Sulfate	68	17
Furosemide	Furosemide	64	23
Sertraline Hcl	Sertraline Hcl	64	19
Duloxetine Hcl	Duloxetine Hcl	62	13
Pravastatin Sodium	Pravastatin Sodium	61	13
Bupropion Xl	Bupropion Hcl	60	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	60	11
Valsartan	Valsartan	60	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	13
Metoprolol Tartrate	Metoprolol Tartrate	57	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	55	45
Synthroid	Levothyroxine Sodium	52	14
Fenofibrate	Fenofibrate	51	14
Carvedilol	Carvedilol	49	13
Fluoxetine Hcl	Fluoxetine Hcl	47	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	14
Prednisone	Prednisone	47	40
Lovastatin	Lovastatin	46	suppressed
Baclofen	Baclofen	45	20
Hydralazine Hcl	Hydralazine Hcl	44	14
Fluticasone Propionate	Fluticasone Propionate	42	20
Eliquis	Apixaban	41	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	15
Pregabalin	Pregabalin	36	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	11
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Trazodone Hcl	Trazodone Hcl	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	25
Donepezil Hcl	Donepezil Hcl	26	suppressed
Famotidine	Famotidine	26	suppressed
Fluconazole	Fluconazole	26	18
Lamotrigine	Lamotrigine	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Verapamil Er	Verapamil Hcl	24	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	15
Acyclovir	Acyclovir	21	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	21	suppressed
Clonazepam	Clonazepam	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Fenofibrate	Fenofibrate,micronized	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Azithromycin	Azithromycin	19	17
Ondansetron Odt	Ondansetron	19	15
Alendronate Sodium	Alendronate Sodium	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Linzess	Linaclotide	17	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	14
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	13
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Topiramate	Topiramate	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Dilantin	Phenytoin Sodium Extended	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error